Major Surgery
Choice to halt RAS therapy before major surgery can be left to patient, physician
Discontinuation of renin-angiotensin system inhibitor therapy before major noncardiac surgery did not appear to affect postoperative outcomes vs. treatment continuation, a speaker reported.
‘Popularity paradox’: Evidence lacking to support lung cancer screening for never-smokers
Current evidence does not support lung cancer screening for never-smokers or former light smokers with a family history of lung cancer, according to a commentary in Journal of Thoracic Oncology.
Major cancer surgery associated with ‘elevated’ risk for venous thromboembolism
Patients who underwent cancer surgery had an increased risk for venous thromboembolism for up to 1 year after the procedure, results from a retrospective study published in JAMA Network Open showed.
Study finds 13% mortality rate among community-living older US adults after major surgery
Study results found a 1-year mortality rate of 13.4% after major surgery among community-living older adults in the United States, with the highest mortality rates seen in those who were frail and had probable dementia.